Market Research Blog

The global diabetic macular edema market size is expected to reach a valuation of US$ 3.7 Bn by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Bn by the end of 2032.

An Uptake of Intravitreal Implants by Patients to Drive Growth of the Market in North America

North America will remain dominant in the global diabetic macular edema market. An uptake of intravitreal implants by new as well as existing patients, who do not show any improvement post-treatment with intravitreal injections, is expected to sustain growth of the market in this region.

Although control of diabetes is a health priority in developed North American countries, such as the U.S., less attention is given to DME management, with diabetes-related caregivers tending to focus on treatment of diabetic complications. A major reason behind this is lack of effective treatment for DME in North America. In addition, an error exists between industry sponsored and independently run clinical trials. Most of the independent clinical trials for DME treatment lack long-term results pertaining to safety and efficacy of new combination therapies for DME. These factors are likely to inhibit growth of the market in North America.

Diabetic Macular Edema Market in Western Europe to Register the Highest CAGR through 2027

The diabetic macular edema market in Western Europe is expected to register a comparatively higher CAGR than other region segments through 2027. Pharmaceutical companies in this region are making substantial investments in research and development, new technologies, and infrastructure in order to capture a market share in the surging burden of eye diseases. This is expected to retain growth of the market in Western Europe.

However, patients in Western Europe resist the intake of intravitreal injections of anti-VEGF drugs, which leads to an instant increase in intraocular pressure causing severe pain in the head or eyes. This a major factor impeding growth of the diabetic macular edema market in Western Europe.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2697

Anti-VEGF will Remain Preferred Product in the Global Diabetic Macular Edema Market

Anti-VEGF will remain preferred product in the market, with sales estimated to expand at 1% CAGR through 2027. Eylea will continue to be the most lucrative anti-VEGF drug in the market. However, demand for corticosteroids will remain comparatively lower than anti-VEGF during the forecast period.

By product form, intravitreal injections will continue to be sought-after in the market, with sales poised to surpass US$ 4,000 Mn by 2027-end. Sales of intravitreal implants will register a comparatively higher CAGR than intravitreal injections through 2027.

Hospital pharmacy is estimated to remain the largest distribution channel in the market, as majority of countries across the globe dispense intravitreal injections and implants to outpatients by hospital pharmacies. Retail pharmacy, which mainly provides aliquots of off-label indications such as Avastin prescription, will register a comparatively low CAGR than hospital pharmacy in the market through 2027.

Key market players identified in FMI’s report include Novartis AG, Bayer AG, Allergan Plc., F. Hoffman-La Roche Ltd., Alimera Sciences Inc., Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Inc.)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-2697

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global continuous renal replacement therapy market was valued at US$ US$ 743 Mn in terms of value in 2016, according to a latest research by Future Market Insights (FMI). The report on continuous renal replacement therapy further projects significant growth potential with average year-on-year growth rate of 7.7% through 2027.

Acute kidney injury (AKI) is a common type of kidney disorder with high morbidity and mortality worldwide. Patients from low-resource regions are more prone to acute kidney injuries. The incidence of acute kidney injuries varies greatly in Asia due to significant variation in climate, geographical attributes, ethnic groups and socioeconomic status.

Continuous renal replacement therapy is conducted for blood purification in patients suffering from acute kidney injury who unable to withstand rapid fluid and electrolyte exchange of conventional hemodialysis. Continuous renal replacement therapy involves the removal of blood from the arterial lumen catheter through the peristaltic movement and pushing it through a hemofilter before getting pumped into a patient via a venous lumen of catheter. Rising incidence of acute kidney injuries, multiple organ failure and other renal injuries had increased the demand for dialysis sessions.

Numerous advantages of continuous renal replacement therapy over the conventional dialysis procedure is a primary factor driving the adoption of continuous renal replacement therapy. Conventional dialysis systems are operated manually and all associated tasks are solely controlled by the user or caregiver. However, technological advancements in currently available continuous renal replacement systems allows the automatic management of disease parameters. Hence, most of the problems are being directly handled by automated digital machines, which is not possible in case of conventional systems, thus reducing the labour cost.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1211

To expand their commercial footprint across the globe, several manufacturers of continuous renal replacement therapy are focusing on introducing new technologies and upgrading their existing products along with simultaneous focus on strategic alliances for the sale and promotion of their products. For instance, in 2015, Fresenius Medical Care AG & Co. KGaA launched multi Filtrate PRO, a therapy system for continuous renal replacement therapy for the treatment of acute kidney failure in critically ill patients at intensive care units. Innovations in extracorporeal technologies will play a critical role in the long-term sustainability of continuous renal replacement therapy devices. The advent of continuous renal replacement therapy devices will eventually attract a new patient base. For instance, in September 2017, Baxter International Inc. launched 3-In-1 oXiris Set for sepsis management protocols & continuous renal replacement therapy, which was previously indicated only for continuous renal replacement therapy. The commercialisation of such multimodal devices is expected to enhance the ROI for hospitals. The introduction of novel autonomous CRRT devices will marginally reduce physician intervention and the cost of treatments in intensive care units. The intuitive platform with touch screen and step-by-step automated instructions promotes ease of use during procedures.

Companies are investing in future growth by expanding their healthcare services businesses through acquisitions as well as the purchase of expertise and relevant technologies in the area of research and development. In 2016, Fresenius Medical Care spent US$1.3 Bn on capital expenditures, acquisitions and the purchase of intangible assets minus income from divestments. The majority of capital expenditures were used for equipping existing & new clinics, preserving & expanding production capacity, primarily in North America, Germany, Asia Pacific and France, as well as for dialysis machines made available to customers and for care coordination.

FMI segmented the global continuous renal replacement therapy market into product type, end user & regions. In terms of revenue, the consumables segment is expected to hold a substantial market share over the forecast period. The segment is expected to exhibit a significant CAGR of 8.5% over the forecast period.

FMI’s report covers some of the key companies operating in the continuous renal replacement therapy market, which include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA, Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.

Browse Full Report:

https://www.futuremarketinsights.com/reports/continuous-renal-replacement-therapy-market

About the Report

FMI has conducted a research study on the continuous renal replacement therapy market for the forecast period of 2017 to 2027. The report offers a comprehensive evaluation of the business opportunities prevailing in the continuous renal replacement therapy market along with insights on the consumption trend, market dynamics, disease incidence, reimbursement, patient awareness level, pricing, company penetration and market competition. The report elaborates on the macro-economic factors influencing the dynamics of the continuous renal replacement therapy market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the continuous renal replacement therapy market based on product type, end user and region. Continuous renal replacement therapy is sold in two types: systems and consumables. The consumables segment covers various types of hemofilter sets, solutions and other accessories.

Increased healthcare spending across emerging economies is expected to encourage the establishment of new multi-specialties in dialysis centres and hospitals, which is, in turn, expected to promote the demand for CRRT. The continuous renal replacement therapy market has been analysed across various regions, which include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and MEA.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1211

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global cancer diagnostics market is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion. Considering this increasing growth and demand in the global market, the cancer diagnostics market is expected to reach US$ 379 Billion by 2032.

Technological advancements in various fields such as biopsy, imaging, biomarkers and endoscopy, rising prevalence of cancer, increase in government initiatives for creating awareness, rapidly increase in geriatric population, and growing government funding are key factors driving the growth of the cancer diagnostics market.

Timely detection of cancer requires suitable diagnostic tests to screen the immunosuppressed population which is at moderate risk of cancer, particularly for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer and melanoma. Growing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among the general population supplements the growth of cancer diagnostics.

Inclusion of cancer screening tests in National Cancer Screening Programs is another major factor expected to fuel the demand for cancer diagnostics. Introduction of regular mammography into national cancer programs by major developed countries where the incidence of breast cancer is high that is leading towards increasing adoption of cancer diagnostics in developed region.

For instance, the U.S. government has included the National Mammography Program in its national cancer screening programs. The government of Australia is taking initiative by conducting 3 cancer screening programs such as the National Cervical Screening Program, BreastScreen Australia and the National Bowel Cancer Screening Program. Similarly, most of the countries in Europe are continuously adopting HPV DNA screening for cervical cancer as a part of national cervical cancer programs.

Short-term Negative Impact Likely Due to COVID-19

The cancer diagnostics market is expected to experience short-term negative growth owing to a reduction in the cancer diagnosis procedures and adoption rate in developed and emerging countries. COVID-19 has impacted the landscape of cancer diagnostics. This has affected demand in various fronts, from prevention to screening and diagnosis, palliative care, treatment, and patient follow-up, to logistics and supplies of cancer diagnostic tests kits and other essential commodities.

Nonetheless after a period of muted growth, the market is poised to recover as economies return to normalcy. As per FMI, the rising incidence of lung cancer is attributable for over 19% of sales in the market.

Key Takeaways from Cancer Diagnostics Market Study

• The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022
• Increasing cases of cancer in the U.S. accounts for 84% of demand in North America
• Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021
• Favorable reimbursement policies will support growth in France and Germany
• Expansion of the healthcare sector will support growth in Japan and South Korea

“Advancements in cancer diagnostics and rising prevalence of cancer are expected to aid growth of cancer diagnostics. A majority of leading players in cancer diagnostic market are adopting strategic partnerships to sustain the increasing competitive pressure,” says the FMI Analyst

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-1090

Who is Winning?

Partnerships between cancer diagnostic assay kits developers, instrument manufacturers and technology licensers are often intended to increase the consumer base.

For instance, in March 2021, Illumina, Inc. signed a partnership agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits by using Illumina’s NextSeq 550Dx sequencing platform for cancer.

In June 2020, Thermo Fisher Scientific signed an agreement with Daiichi Sankyo to Co-launch a companion diagnostic for patients with non-small cell lung cancer for identifying Her2 gene mutations using the Oncomine Dx target test.

Cancer Diagnostics Market by Category

Test Type

• Tumour Biomarkers Tests
  • PSA Tests
  • CTC Tests
  • AFP Tests
  • CA Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • CEA Tests
  • EGFR Mutation Tests
  • KRAS Mutation Tests
  • Others
• Imaging
  • Ultrasound
  • Mammography
  • MRI Scan
  • PET Scan
  • CT Scan
  • SPECT & Others
• Biopsy
  • Needle Biopsy
  • Endoscopic Biopsy
  • Bone Marrow Biopsy
  • Others
• Liquid Biopsy
• Immunohistochemistry
• In Situ Hybridization

Indication

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Blood Cancer
• Prostate Cancer
• Ovarian Cancer
• Stomach Cancer
• Liver Cancer
• Others

End-user

• Hospital Associated Labs
• Independent Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Others

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1090

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Market Dynamics

2.4. Inclusions and Exclusions

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Global GDP Growth Outlook

3.1.2. Global Healthcare Expenditure Outlook

3.1.3. Growth of Healthcare Sector in Emerging Nations

3.2. Forecast Factors – Relevance & Impact

3.2.1. Global Increase in Healthcare Expenditure

3.2.2. Rising Prevalence of Cancer

3.2.3. Changing Regulatory Dynamics

3.2.4. Cost Impact

3.2.5. Regulatory Scenario

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunity Analysis

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1090

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

As per a study by ESOMAR-certified consulting firm Future Market Insights (FMI), The teleradiology market is projected to register a CAGR of 15.3% during the forecast period, up from US$ 7.3 Bn in 2021. Favored by the increasing number of medical imaging procedures such as computed tomography (CT) scans and X-ray scans, the sales of teleradiology are likely to surge at a vigorous 15.3% CAGR during the assessment period.

Rising prevalence of diseases such as cancer, arthritis, cellulitis, and osteomyelitis are facilitating the market growth. According to the National Institute of Cancer, around 1898,160 new incidences of cancer are estimated to be diagnosed in 2021, causing approximately 608,570 deaths in the U.S.

As teleradiology enables the transfer of radiological images to qualified radiologists for providing effective treatments, it plays a life-saving function for patients. Thus, with the increasing number of cancer cases and lack of availability of skilled radiologists in sub-urban and rural areas, the demand for teleradiology systems is likely to increase over the coming year.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1747

The coronavirus outbreak has favored the teleradiology market by increasing demand for medical imaging procedures across the globe. As the use of teleradiology systems avoids in-person contacts for the exchange of hard imaging result copies, these systems are increasingly being adopted by hospitals, medical institutes, and clinics for sharing study observations and details information gathered, thereby, driving teleradiology sales.

Key Takeaways from FMI’s Teleradiology Market Study

Sales of teleradiology systems are expected to rise at 9.10% between 2020 and 2021.

• The U.S. is estimated to dominate the North America teleradiology market owing to the presence of leading market players in the country.
• China is likely to emerge as the prominent market in Asia Pacific due to the high prevalence of chronic diseases such as cancer and arthritis.
• Based on modality, CT scans are anticipated to lead the segment, on the back of rising digitalization and technological advancements in the segment.
• Owing to the surging demand for diagnostic imaging procedures due to the lack of qualified radiologists, ambulatory imaging centres (AICs) are expected to account for substantial revenue share.

Competitive Landscape

Teleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings, Inc., Vital Radiology Services, and Telemedicine Clinic are the leading players operating in the teleradiology market as profiled by FMI.

The teleradiology market is highly fragmented owing to the presence of large number of market players. Leading player emphasizing on launching the new products and expanding their product portfolio to gain competitive edge over other player. Besides, this some of the players are adopting strategies such as strategic collaboration, merger, acquisition, and partnership with other industry players to strength their market footprint.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1747

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The report, titled “North America’s medical carts market size Analysis and Opportunity Assessment, 2017-2027,” also projects that manufacturers of medical carts are extending the product line by introducing medical carts with added features. Omnicell, Inc., Herman Miller, Inc., The Harloff Company, Capsa Solutions LLC, Medline Industries, Inc., Armstrong Medical Industries, Inc., AFC Industries, Waterloo Healthcare, TouchPoint Medical, and Ergotron, Inc. are recognised as leading manufacturers of medical carts in North America.

Rising focus on point-of-care diagnosis & treatment has led to an increase in the use of mobile computer medical carts. Computer medical carts are used to record and update a patient’s electronic health records (EHR). Increased adoption of Electronic Health Records (EHR) is also observed to be an instrumental factor for growth of North America’s medical carts market.

The need for streamlining workflow has necessitated the integration of information technology (IT) solutions in healthcare settings. Medical carts manufactured by companies are presently serving the essential purpose of aiding nursing operations in medical facilities. The robust healthcare infrastructure in the US will demand the adoption of advanced medical carts that not only dispense medical instruments & supplies, but also have integrated IT systems. In the years to come, the demand for medical carts in North America will witness steadfast inclination towards IT-integrated medical carts.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-na-3608

Constructive Prospects for Future of North America’s Medical Carts Market

A lucrative opportunity for such prominent medical device manufacturers towards consolidating their presence in the medical carts market in North America is changing their product line in accordance with shift in technology. Mechanical medical carts are being gradually replaced by new and enhanced technologies such as powered medical devices with battery systems, locking drawers (with negative tilt to facilitate efficient stocking of medication), and automated medicine dispensing systems.

In addition to this, increased focus on acquisitions and collaboration among companies have helped them expand their clinical carts product portfolio and cater to the demand for efficient healthcare systems. This has boosted the need for more effective and advanced medical equipment, devices and procedures. Emerging players must keep in mind that acquisitions over the years have resulted in strengthening the positions of current market leaders.

Key Highlights of the Report follow,

• In 2017 and beyond, computer medical carts will remain in great demand, procuring close to 40% of the market’s overall revenues towards the end of 2027
• North America’s medical carts market is poised to witness dominance of metal as base material, revenues from which will reflect a CAGR of 12.1%
• Non-powered medical carts will also be top-sellers in the market, while revenues from sales of powered medical carts are anticipated to showcase 12.6% CAGR
• Hospitals will be the largest end-users of medical carts in North America

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-na-3608

 Key Segments:

By End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centres
• Diagnostic Centres
• Others

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• MEA

By Material Type:

• Metal
• Plastic
• Wood

By Energy Source:

• Powered
• Non-Powered (Mechanical)

By Product Type:

• Emergency Carts
• Procedure/Treatment Carts
• Anaesthesia Carts
• Medical Computer Carts
• Others

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-na-3608

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Europe Hospital Capacity Management Solutions Market Size Industry Analysis and Opportunity Assessment, 2017-2027. Expansion of patient care due to high incidences of chronic and infectious diseases has compelled hospitals to invest heavily in streamlining their operations. In recent years, rapid technological advancements have made it possible to integrate artificial intelligence to enhance healthcare. Adoption of hospital capacity management solutions has ushered in a smooth workflow by reducing maintenance downtime and yielding significant cost savings.

Hospital capacity management solutions enables executives, administrators, and clinical staff working in hospitals to more effectively manage capacity and tracking. When it comes to planning and tracking, it brings about improved resource planning and utilization which ups efficiency and productivity. It also brings about visibility and forecast through improved tracking and metrics. Adoption of hospital management capacity solutions will grow at 5.1% CAGR through 2027, according to a latest research by Future Market Insights (FMI)..

Investments in real time location systems (RTLS) and cloud-based monitoring solutions are on the rise across hospitals worldwide. A host of advantages such as improvements in patient flow, faster room turnover, throughput optimization and automated occupancy and discharge are driving increased adoption of RTLS systems across healthcare settings. It also facilitates effective asset management.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-eu-3520

The ongoing coronavirus pandemic has only accelerated the need for hospital capacity management solutions. The pandemic has burgeoned demand for point-of-care access to medical records, upscaling the need to implement cloud based solutions in the upcoming forecast period. Furthermore, demand for wireless monitoring devices has ascended, enabling doctors to prescribe effective treatment to the infected patients without the need to come in direct contact.

“Saturation of operations and an overburdened staff have pushed healthcare providers to allocate their funds towards procuring advanced capacity management solutions. They are therefore collaborating with software behemoths to provide effective cloud-based hospital capacity management solutions,” concludes an FMI analyst.

Key Takeaways from FMI’s Hospital Capacity Management Solutions Report

• Manufacturers are emphasizing on integrated management solutions to facilitate multiple supervisory operations simultaneously
• More than 30% of the hospital capacity management solutions needs are met by RTLS, attributed to the utilization of system-based crisis response and emergency management
• North America and Europe collectively enjoyed 70% of the global hospital capacity management market revenue in 2019 while developing countries are seen as potential future investment hubs
• HCMS market in Germany is expected to surpass US$ 80 Mn by 2027

Hospital Capacity Management Solutions Market- Key Trends

• Mushrooming demand for enhanced healthcare facilities in the wake of rapidly evolving health complications is providing traction to hospital capacity management solutions since a long time
• Implementation of technologically advanced hospital capacity management solutions is being advocated by governments, setting aside a major chunk of their budgets in streamlining hospital care
• Hospitals are collaborating with leading software and IT companies to design and implement state-of-the-art capacity management solutions, thereby spurring high investment inflow

Hospital Capacity Management Solutions Market- Region-wise Analysis

• Increasing adoption of e-health solutions, demand for reduction in labor costs and waiting time for patients is driving capacity management solutions across hospitals in North America and Europe
• Brazil, India, China and South Africa are expected to experience a massive upsurge in the adoption of hospital capacity management solutions. Increase in ICT spending and high patient pool are the key drivers

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-eu-3520

Hospital Capacity Management Solutions Market- Competitive Landscape

A number of players have penetrated the hospital capacity management market landscape over the past few years. In this study, these players have been profiled according to their regional prominence.

In the Americas, the prominent players include STANLEY Healthcare, Sonitor Technologies Inc., Cerner Corporation, Epic Systems Corporation and TeleTracking Technologies, Inc. among others. The European landscape is dominated by two main players: Koninklijke Philips N.V and Acromed AG while the Asia-Pacific landscape contains Neusoft Corporation, JVS Group, INFINITT Healthcare Co Ltd and Infosys Limited.

All these players primarily focus on acquiring greater market shares by virtue of organic growth strategies such as expansion of product portfolios in the software sector. For instance, in May 2020, STANLEY Healthcare announced the incorporation of the Aero Scout RTLS certified by Cisco DNA Spaces.

In March 2020, Neusoft Medical Systems established a robust cloud-enabled platform in collaboration with the Kenyatta National Hospital in Nairobi to provide proper diagnosis to COVID-19 patients.

Market Taxonomy

By Product Type:

• Workflow Management Solutions
• Asset Management Solutions
• Bed Management Solutions
• Quality Patient Care Solutions
• Real Time Locating System (RTLS)
• Event Driven Solutions
  • Online Registration Solutions
  • Attendance Management Tools
  • Event Driven Patient Tracking
  • Others

By Application:

• Standalone Solutions
• Integrated Solutions

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-eu-3520

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs